---
title: "Testagen"
canonical_url: https://peptidelibrary.app/library/testagen
description: "Short peptide sold as a testicular/endocrine bioregulator. Not FDA-approved; not a testosterone secretagogue with modern RCT evidence."
updated: 2026-11-07
publisher: Peptide Library
notice: "Research and educational use only. Not medical advice."
---

# Testagen

Testagen (also called Testis bioregulator or Lys-Glu-Asp-Gly) is a khavinson endocrine bioregulator. Testagen is Lys-Glu-Asp-Gly, a synthetic tetrapeptide in the Khavinson series associated with testicular tissue. The proposed mechanism is the series hypothesis of short peptides binding DNA promoter regions in the nucleus and modulating transcription, with reported effects on Leydig and Sertoli cell protein synthesis and on reproductive parameters in animal models.

Short peptide sold as a testicular/endocrine bioregulator. Not FDA-approved; not a testosterone secretagogue with modern RCT evidence.

Also known as: Testis bioregulator, Lys-Glu-Asp-Gly.

Categories: Experimental.

## Classification

- Type: Khavinson endocrine bioregulator / research
- Mechanism class: Short Peptide Bioregulator
- Development stage: Research only
- Regulatory class: Research compound, not FDA-approved

## Mechanism

Testagen is Lys-Glu-Asp-Gly, a synthetic tetrapeptide in the Khavinson series associated with testicular tissue. The proposed mechanism is the series hypothesis of short peptides binding DNA promoter regions in the nucleus and modulating transcription, with reported effects on Leydig and Sertoli cell protein synthesis and on reproductive parameters in animal models. Supporting evidence is cell-culture and cytogenetic work from a single group in Russian-language publications. It is not a treatment for hypogonadism, has no controlled human efficacy data, and is not a substitute for approved testosterone therapy.

Targets: Testicular cells (proposed).

Origin: Synthetic short peptide.

## Properties

- Sequence: H Lys Glu Asp Gly OH (KEDG)
- Molecular formula: C17H29N5O9
- Molecular weight: 447.44 g/mol
- CAS number: 1026993-38-3
- Half-life: Not established (limited public PK data; primarily research context)

## Evidence

- Evidence level: Insufficient Evidence
- Highest documented: Lab & animal studies
- Human trials: 0
- Controlled human trials: 0
- Preclinical sources: 3
- Latest source: 2013

No human dose is established for this compound.

Each step shows whether the sources Peptide Library has reviewed include that kind of research. Counts are reviewed sources, not every study ever published. Reviews and programme summaries that describe human use are shown as "reported", not as trials, and registered trials without published results are listed but not counted. A higher step means research has progressed further; it does not mean a compound works better or is safer. Compounds whose evidence has not been reviewed yet show "Not reviewed" instead of a guess.

### Studies

1. Effect of tetrapeptides Lys-Glu-Asp-Gly and Ala-Glu-Asp-Gly on the structure and function of the thyroid gland in neonatally hypophysectomized chickens. Bull Exp Biol Med. 2008. 2008. Preclinical: animal or lab study. Population: Chickens whose pituitary gland was removed after hatching. Higher thyrotropic and thyroid hormone levels and recovery of thyroid structure. Limitations: Lab or animal research: not evidence of a human effect or dose. [Source](https://pubmed.ncbi.nlm.nih.gov/19024016/)
2. Effect of peptides Lys-Glu-Asp-Gly and Ala-Glu-Asp-Gly on the morphology of the thymus in hypophysectomized young and old birds. Bull Exp Biol Med. 2013. 2013. Preclinical: animal or lab study. Population: Young and old chickens after pituitary removal. Recovery of thymus structure, more marked with KEDG than with AEDG. Limitations: Lab or animal research: not evidence of a human effect or dose. [Source](https://pubmed.ncbi.nlm.nih.gov/23658898/)
3. Penetration of short fluorescence-labeled peptides into the nucleus in HeLa cells and in vitro specific interaction of the peptides with deoxyribooligonucleotides and DNA. Biochemistry (Mosc). 2011. 2011. Preclinical: in vitro (cells or tissue). Population: HeLa cells and isolated DNA fragments. Labelled testagen entered the cytoplasm, nucleus and nucleolus, and bound DNA fragments in a sequence-dependent way. Limitations: Lab or animal research: not evidence of a human effect or dose. [Source](https://pubmed.ncbi.nlm.nih.gov/22117547/)

## Safety

Side effects: Not characterized.

Risks: Research-only.

Human safety basis: No controlled human safety data

Key limitations: No established human dosage.; No controlled human trial results in the reviewed sources.; Not approved by the FDA for any use..

## Regulatory status

Testagen is not an FDA-approved product. It is sold for laboratory research and has no approved medical use.

- FDA status: Not Approved
- Availability: Research-Only

## Frequently asked questions

### What is Testagen?

Short peptide sold as a testicular/endocrine bioregulator. Not FDA-approved; not a testosterone secretagogue with modern RCT evidence.

### How does Testagen work?

Testagen is Lys-Glu-Asp-Gly, a synthetic tetrapeptide in the Khavinson series associated with testicular tissue. The proposed mechanism is the series hypothesis of short peptides binding DNA promoter regions in the nucleus and modulating transcription, with reported effects on Leydig and Sertoli cell protein synthesis and on reproductive parameters in animal models.

### Is Testagen FDA approved?

No. Testagen is not approved by the FDA for any indication and is categorised as research-only. It has not been reviewed for safety or efficacy as a medicine, and published research should be read as investigation rather than established use.

### What is the half-life of Testagen?

Reported half-life for Testagen is Not established (limited public PK data; primarily research context). Half-life describes how long the compound persists in circulation, not how long any effect lasts, and published figures vary with route of administration, formulation and the population studied.

### What is the amino acid sequence of Testagen?

Testagen has the sequence H Lys Glu Asp Gly OH (KEDG). Its molecular formula is C17H29N5O9.

### What peptides are similar to Testagen?

Compounds most often compared with Testagen include Bonomarlot, Bronchogen, Cardiogen and Cartalax. They are grouped by shared mechanism or research area rather than by equivalence, and their regulatory status and evidence base differ.

## References

- [Effect of peptides Lys-Glu-Asp-Gly and Ala-Glu-Asp-Gly on the morphology of the thymus in hypophysectomized young and old birds — Bull Exp Biol Med, 2013](https://pubmed.ncbi.nlm.nih.gov/23658898/)
- [\[Effects of Lys-Glu-Asp-Gly and Ala-Glu-Asp-Gly peptides on hormonal activity and thyroid morphology in hypophysectomized mature and old birds\] — Adv Gerontol, 2011](https://pubmed.ncbi.nlm.nih.gov/21809626/)
- [Effects of peptides Lys-Glu-Asp-Gly and Ala-Glu-Asp-Gly on hormonal activity and structure of the thyroid gland in hypophysectomized young chickens and old hens — Bull Exp Biol Med, 2011](https://pubmed.ncbi.nlm.nih.gov/22268052/)
- [\[Effects of hypophyseal Lys-Glu-Asp-Gly and Ala-Glu-Asp-Gly synthetic peptides on immunity, hemostasis, morphology and functions of the thyroid gland in neonatally hypophysectomized chicken and one-year-old birds\] — Patol Fiziol Eksp Ter, 2010](https://pubmed.ncbi.nlm.nih.gov/20731122/)
